Canadian Bioceutical Obtains DTC Eligibility

The Canadian Bioceutical Corporation (CSE:BCC, OTCQB:CBICF) has secured a DTC eligibility by The Depository Trust Company for its OTCQB shares.
As quoted in the press release:

DTC-eligibility greatly simplifies the process of trading and exchanging BCC common stock on the OTCQB marketplace in the United States.  The Company commenced trading on the OTCQB on May 22, 2017, a move that management anticipates will increase the Company’s addressable universe of potential investors.

The Depository Trust Company (DTC) is a subsidiary of the Depository Trust & Clearing Corporation DTCC, and manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through the DTC are considered “DTC eligible.” This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors.

Click here to read the full press release.

Source: canadianbioceutical.com